AACR Announces New Editor-in-Chief of Cancer Research
January 4, 2010
The American Association for Cancer Research welcomes George C. Prendergast, Ph.D., as the new editor-in-chief of Cancer Research, the oldest journal of the American Association for Cancer Research. Prendergast, president and CEO of Lankenau Institute for Medical Research in Wynnewood, Pa., assumed the post on January 1, 2010, and will serve for five years.
"My goal is to make Cancer Research the top journal for those scientists who are interested in the management and eradication of cancer," said Prendergast. "There are other journals that present different perspectives on the problem of cancer, but Cancer Research will be the 'go to' source for laboratory and translational scientists who are interested in real improvements rather than just interesting concepts."
Cancer Research is published twice a month, and will celebrate its 70th year of publication in 2011.
"The American Association for Cancer Research is proud to have a prominent scientist like Dr. Prendergast take lead of our premier journal," said Margaret Foti, Ph.D., M.D. (h.c.), CEO of the American Association for Cancer Research. "His in-depth knowledge of the biological basis for drug development and molecular underpinnings of cancer will help drive the field forward."
Prendergast had previously served as a senior editor and deputy editor for Cancer Research. He has been honored with numerous accolades from the Pew Foundation, the National Institutes of Health and the American Cancer Society. His primary research interests include the molecular and cellular biology of cancer, cancer immunology, preclinical models of cancer progression and therapy and drug discovery and mechanisms. He is an author on several early scientific papers on the mechanisms of action for drugs that are now in clinical development.
Prendergast received his doctorate in molecular biology from Princeton University in 1989, a Master of Science in molecular biophysics and biochemistry from Yale University in 1984 and a Bachelor of Arts in biochemistry from the University of Pennsylvania in 1983.
Listen to Dr. Prendergast talk about the journal and his goals as editor-in-chief:
* the mp3 of the teleconference (3.95 MB, 5 minutes and 44 seconds, Requires QuickTime
*On a PC, right mouse click on the "Download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.
Read Dr. Prendergast’s editorial in the Jan. 1 issue of Cancer Research.
Subscribe to the AACR Scientific Podcast feed through the following:
Subscribe to the AACR Scientific Podcast via a RSS Reader
Subscribe to the AACR RSS News Feed.
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 30,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and nearly 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 16,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.